Lifestyle and Pharmacotherapy for Weight Loss in Preventing or Delaying Diabetes

Stephanie Price, Quynh Nhu Le, Nicole D. White

Research output: Contribution to journalReview articlepeer-review

2 Scopus citations


Preventing or delaying the conversion of prediabetes to overt diabetes can reduce mortality and morbidity rates, improve health-related quality of life, and reduce other comorbid complications associated with diabetes. Studies have shown that a modest weight loss is one strategy for preventing or delaying diabetes diagnosis. First-line therapy in preventing progression of prediabetes to overt diabetes is weight loss through lifestyle modifications; however, pharmacotherapy for weight loss may be initiated if lifestyle alone is ineffective. The purpose of this article is to describe the pharmacotherapeuptic options for weight loss that can be used in conjunction with lifestyle in the prevention or delay of diabetes in patients with prediabetes.

Original languageEnglish (US)
Pages (from-to)34-37
Number of pages4
JournalAmerican Journal of Lifestyle Medicine
Issue number1
StatePublished - Jan 1 2018

All Science Journal Classification (ASJC) codes

  • Medicine (miscellaneous)
  • Health Policy
  • Public Health, Environmental and Occupational Health


Dive into the research topics of 'Lifestyle and Pharmacotherapy for Weight Loss in Preventing or Delaying Diabetes'. Together they form a unique fingerprint.

Cite this